Genetic Etiology for Alcohol-Induced Cardiac Toxicity

James S Ware, Almudena Amor-Salamanca, Upasana Tayal, Risha Govind, Isabel Serrano, Joel Salazar-Mendiguchía, Jose Manuel García-Pinilla, Domingo A Pascual-Figal, Julio Nuñez, Gonzalo Guzzo-Merello, Emiliano Gonzalez-Vioque, Alfredo Bardaji, Nicolas Manito, Miguel A López-Garrido, Laura Padron-Barthe, Elizabeth Edwards, Nicola Whiffin, Roddy Walsh, Rachel J Buchan, William Midwinter, Alicja Wilk, Sanjay Prasad, Antonis Pantazis, John Baski, Declan P O'Regan, Luis Alonso-Pulpon, Stuart A Cook, Enrique Lara-Pezzi, Paul J Barton, Pablo Garcia-Pavia, James S Ware, Almudena Amor-Salamanca, Upasana Tayal, Risha Govind, Isabel Serrano, Joel Salazar-Mendiguchía, Jose Manuel García-Pinilla, Domingo A Pascual-Figal, Julio Nuñez, Gonzalo Guzzo-Merello, Emiliano Gonzalez-Vioque, Alfredo Bardaji, Nicolas Manito, Miguel A López-Garrido, Laura Padron-Barthe, Elizabeth Edwards, Nicola Whiffin, Roddy Walsh, Rachel J Buchan, William Midwinter, Alicja Wilk, Sanjay Prasad, Antonis Pantazis, John Baski, Declan P O'Regan, Luis Alonso-Pulpon, Stuart A Cook, Enrique Lara-Pezzi, Paul J Barton, Pablo Garcia-Pavia

Abstract

Background: Alcoholic cardiomyopathy (ACM) is defined by a dilated and impaired left ventricle due to chronic excess alcohol consumption. It is largely unknown which factors determine cardiac toxicity on exposure to alcohol.

Objectives: This study sought to evaluate the role of variation in cardiomyopathy-associated genes in the pathophysiology of ACM, and to examine the effects of alcohol intake and genotype on dilated cardiomyopathy (DCM) severity.

Methods: The authors characterized 141 ACM cases, 716 DCM cases, and 445 healthy volunteers. The authors compared the prevalence of rare, protein-altering variants in 9 genes associated with inherited DCM. They evaluated the effect of genotype and alcohol consumption on phenotype in DCM.

Results: Variants in well-characterized DCM-causing genes were more prevalent in patients with ACM than control subjects (13.5% vs. 2.9%; p = 1.2 ×10-5), but similar between patients with ACM and DCM (19.4%; p = 0.12) and with a predominant burden of titin truncating variants (TTNtv) (9.9%). Separately, we identified an interaction between TTN genotype and excess alcohol consumption in a cohort of DCM patients not meeting ACM criteria. On multivariate analysis, DCM patients with a TTNtv who consumed excess alcohol had an 8.7% absolute reduction in ejection fraction (95% confidence interval: -2.3% to -15.1%; p < 0.007) compared with those without TTNtv and excess alcohol consumption. The presence of TTNtv did not predict phenotype, outcome, or functional recovery on treatment in ACM patients.

Conclusions: TTNtv represent a prevalent genetic predisposition for ACM, and are also associated with a worse left ventricular ejection fraction in DCM patients who consume alcohol above recommended levels. Familial evaluation and genetic testing should be considered in patients presenting with ACM.

Keywords: alcohol; dilated cardiomyopathy; genetics; titin; variant.

Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Figures

Graphical abstract
Graphical abstract
Figure 1
Figure 1
Survival Analysis of ACM Cases According to Genotype Survival curves show freedom from composite primary endpoint (all-cause mortality or cardiac transplant) between ACM cases stratified by genetic status: TTNtv positive (cases with a truncating variant in titin) or TTNtv negative. Event-free survival is measured from time of diagnosis. There is no significant difference between groups. Curves are compared using the log-rank test. ACM = alcoholic cardiomyopathy; TTNtv = titin truncating variant.
Figure 2
Figure 2
Alcohol and TTNtv Act in Combination, and Together Are Associated With a Lower Baseline LVEF in Patients With DCM Forest plot showing regression coefficient and 95% confidence intervals from the multivariable linear regression model evaluating the effects of TTNtv and excess alcohol consumption on baseline LVEF. The effect on LVEF is shown as absolute difference in LVEF (% = expressed as percentage of end-diastolic volume) between groups. A-Antag = aldosterone antagonist; Alcohol XS = excess alcohol consumption (binary variable indicating consumption >21 U/week for men, >14 U/week for women); LGE = late gadolinium enhancement (indicative of mid-wall fibrosis) on cardiovascular magnetic resonance; LVEF = left ventricular ejection fraction; TTNtv = presence of truncating variant in titin; TTNtv*Alcohol XS = interaction term representing individuals with both a TTNtv and a history of excess alcohol consumption.
Central Illustration
Central Illustration
Alcohol Consumption and Genetic Background Act in Concert to Determine Cardiac Phenotype ACM patients exhibit a higher prevalence of rare variants in DCM-associated genes than control subjects. In DCM patients, neither the presence of a TTNtv nor excess alcohol consumption had a significant effect on baseline LVEF in isolation, but the combination was associated with a significantly lower baseline LVEF. Values shown are absolute ejection fraction in each group. The p value is derived from multivariate analysis. ACM = alcoholic cardiomyopathy; DCM = dilated cardiomyopathy; LVEF = left ventricular ejection fraction; TTNtv = titin truncating variant.
Figure 3
Figure 3
Family Pedigrees Illustrating Coexistence of ACM and DCM and the Combined Effect of Excessive Alcohol Consumption and Genetic Background (Top) Family 978: coexistence of ACM and DCM. The proband (arrow) was diagnosed with ACM and underwent cardiac transplantation. When genetic and clinical familial evaluation was performed, multiple individuals without excessive alcohol consumption were diagnosed with DCM and found to carry TTN truncating variants. (Bottom) Family 1016: combined effect of excessive alcohol consumption and genetic background. The proband (arrow) was diagnosed with ACM at age 44 years and was identified as carrying a TTNtv variant (TTN c.64453C>T; p.R21485X). One brother and 1 sister with prolonged heavy alcohol consumption (red asterisk) and TTNtv also show ACM. Two family members with TTNtv but no regular alcohol intake, and 2 individuals with prolonged heavy alcohol consumption but without TTNtv, did not show cardiac involvement. Standard pedigree notation is used: squares and circles indicate male and female subjects, respectively, a strike-through indicates a deceased individual, an arrow indicates the proband in each family, and filled symbols indicate affected individuals with ACM or DCM. Symbols containing an N represent individuals confirmed as unaffected. +/− symbols indicate genetic evaluation: + indicates carry TTNtv; are noncarriers, o+ are obligate carriers. Red asterisks indicate cases with documented prolonged heavy alcohol consumption. CTx = cardiac transplant; DCM = dilated cardiomyopathy; MI = myocardial infarction; SCA = sudden cardiac arrest; VHD = valvular heart disease; other abbreviations as in Figure 1.

References

    1. Urbano-Marquez A., Estruch R., Navarro-Lopez F., Grau J.M., Mont L., Rubin E. The effects of alcoholism on skeletal and cardiac muscle. N Engl J Med. 1989;320:409–415.
    1. Fernandez-Sola J. Cardiovascular risks and benefits of moderate and heavy alcohol consumption. Nat Rev Cardiol. 2015;12:576–587.
    1. Guzzo-Merello G., Segovia J., Dominguez F. Natural history and prognostic factors in alcoholic cardiomyopathy. J Am Coll Cardiol HF. 2015;3:78–86.
    1. George A., Figueredo V.M. Alcoholic cardiomyopathy: a review. J Card Fail. 2011;17:844–849.
    1. Xi B., Veeranki S.P., Zhao M., Ma C., Yan Y., Mi J. Relationship of alcohol consumption to all-cause, cardiovascular, and cancer-related mortality in U.S. adults. J Am Coll Cardiol. 2017;70:913–922.
    1. Guzzo-Merello G., Cobo-Marcos M., Gallego-Delgado M., Garcia-Pavia P. Alcoholic cardiomyopathy. World J Cardiol. 2014;6:771–781.
    1. Fernandez-Sola J., Nicolas J.M., Oriola J. Angiotensin-converting enzyme gene polymorphism is associated with vulnerability to alcoholic cardiomyopathy. Ann Intern Med. 2002;137:321–326.
    1. Teragaki M., Takeuchi K., Toda I. Point mutations in mitochondrial DNA of patients with alcoholic cardiomyopathy. Heart Vessels. 2000;15:172–175.
    1. Guzzo-Merello G., Dominguez F., Gonzalez-Lopez E. Malignant ventricular arrhythmias in alcoholic cardiomyopathy. Int J Cardiol. 2015;199:99–105.
    1. Hershberger R.E., Hedges D.J., Morales A. Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat Rev Cardiol. 2013;10:531–547.
    1. Herman D.S., Lam L., Taylor M.R. Truncations of titin causing dilated cardiomyopathy. N Engl J Med. 2012;366:619–628.
    1. Roberts A.M., Ware J.S., Herman D.S. Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease. Sci Transl Med. 2015;7:270ra6.
    1. Tayal U., Prasad S., Cook S.A. Genetics and genomics of dilated cardiomyopathy and systolic heart failure. Genome Med. 2017;9:20.
    1. Ware J.S., Li J., Mazaika E. Shared genetic predisposition in peripartum and dilated cardiomyopathies. N Engl J Med. 2016;374:233–241.
    1. Schafer S., de Marvao A., Adami E. Titin-truncating variants affect heart function in disease cohorts and the general population. Nat Genet. 2017;49:46–53.
    1. Amor-Salamanca A., Guzzo-Merello G., González-López E. Prognostic impact and predictors of ejection fraction recovery in patients with alcoholic cardiomyopathy. Rev Esp Cardiol. 2018 Feb 8 [E-pub ahead of print]
    1. Tayal U., Newsome S., Buchan R. Integrated analysis of the phenotype and clinical outcomes of Titin cardiomyopathy. J Am Coll Cardiol. 2017;70:2264–2274.
    1. Maceira A.M., Prasad S.K., Khan M., Pennell D.J. Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2006;8:417–426.
    1. Pua C.J., Bhalshankar J., Miao K. Development of a comprehensive sequencing assay for inherited cardiac condition genes. J Cardiovasc Transl Res. 2016;9:3–11.
    1. Whiffin N., Minikel E., Walsh R. Using high-resolution variant frequencies to empower clinical genome interpretation. Genet Med. 2017;19:1151–1158.
    1. Walsh R., Thomson K.L., Ware J.S. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Med. 2017;19:192–203.
    1. Committee HoCSaT. Alcohol guidelines: Eleventh Report of Session 2010-12: UK Parliament, 2012.
    1. Royal Colleges of Physicians, Psychiatrists and General Practitioners . Royal Colleges of Physicians; London: 1995. Alcohol and the Heart in Perspective: Sensible Limits Reaffirmed.
    1. ImperialCardioGenetics/ACM. Available at: . Accessed April 15, 2018.
    1. Chami N., Tadros R., Lemarbre F. Nonsense mutations in BAG3 are associated with early-onset dilated cardiomyopathy in French Canadians. Can J Cardiol. 2014;30:1655–1661.
    1. Richards S., Aziz N., Bale S. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–424.
    1. Ware J.S., Cook S.A. Role of titin in cardiomyopathy: from DNA variants to patient stratification. Nat Rev Cardiol. 2018;15:241–252.
    1. Bell S., Daskalopoulou M., Rapsomaniki E. Association between clinically recorded alcohol consumption and initial presentation of 12 cardiovascular diseases: population based cohort study using linked health records. BMJ. 2017;356:j909.
    1. Belkaya S., Kontorovich A.R., Byun M. Autosomal recessive cardiomyopathy presenting as acute myocarditis. J Am Coll Cardiol. 2017;69:1653–1665.
    1. Marinescu V., McCullough P.A. Nutritional and micronutrient determinants of idiopathic dilated cardiomyopathy: diagnostic and therapeutic implications. Expert Rev Cardiovasc Ther. 2011;9:1161–1170.
    1. Frustaci A., Russo M.A., Morgante E. Oxidative myocardial damage in human cocaine-related cardiomyopathy. Eur J Heart Fail. 2015;17:283–290.
    1. Chang H.M., Okwuosa T.M., Scarabelli T. Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 2. J Am Coll Cardiol. 2017;70:2552–2565.
    1. Felkin L.E., Walsh R., Ware J.S. Recovery of cardiac function in cardiomyopathy caused by titin truncation. JAMA Cardiol. 2016;1:234–235.
    1. Jansweijer J.A., Nieuwhof K., Russo F. Truncating titin mutations are associated with a mild and treatable form of dilated cardiomyopathy. Eur J Heart Fail. 2017;19:512–521.

Source: PubMed

3
구독하다